Skip to content

Measurement of mRNA of predictive factors to chemotherapy in patients with superficial bladder cancer

Measurement of mRNA of predictive factors to chemotherapy in patients with superficial bladder cancer - Measurement of predictive factors to chemotherapy in patients with superficial bladder cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000003558
Enrollment
50
Registered
2010-05-06
Start date
2010-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

None listed

Sponsors

Department of Urology, Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients with superficial bladder cancer who underwent trans urethral resection of bladder tumor at Keio University Hospital between 1992 and 2007.

Exclusion criteria

Exclusion criteria: The patients who have active other cancers, or received the treatment of bladder cancer at other hospital, or cannot come to hospital after operation regularly.

Design outcomes

Primary

MeasureTime frame
To evaluate the association between the values of TS, DPD and OPRT and 1)pathological staging (TNM classification), 2)grade, 3)recurrence, 4)progression 5) metastasis 6) death

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026